12/12
11:59 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
12/12
11:59 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
12/12
10:02 am
abbv
AbbVie (NYSE:ABBV) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
AbbVie (NYSE:ABBV) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
12/12
10:02 am
abbv
AbbVie (NYSE:ABBV) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
AbbVie (NYSE:ABBV) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
12/10
07:01 am
abbv
AbbVie (NYSE:ABBV) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating.
Low
Report
AbbVie (NYSE:ABBV) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating.
12/10
06:50 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
12/10
06:50 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
12/10
05:06 am
abbv
AbbVie upgraded to Buy from Hold at HSBC
Low
Report
AbbVie upgraded to Buy from Hold at HSBC
12/10
05:06 am
abbv
AbbVie upgraded to Buy from Hold at HSBC
Low
Report
AbbVie upgraded to Buy from Hold at HSBC
11/14
07:50 am
abbv
AbbVie (NYSE:ABBV) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Low
Report
AbbVie (NYSE:ABBV) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
11/14
07:50 am
abbv
AbbVie (NYSE:ABBV) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Low
Report
AbbVie (NYSE:ABBV) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
11/13
09:53 am
abbv
AbbVie (NYSE:ABBV) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $280.00 price target on the stock.
Low
Report
AbbVie (NYSE:ABBV) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $280.00 price target on the stock.
11/13
09:53 am
abbv
AbbVie (NYSE:ABBV) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $280.00 price target on the stock.
Low
Report
AbbVie (NYSE:ABBV) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $280.00 price target on the stock.
11/12
04:17 pm
abbv
AbbVie initiated with an Outperform at Scotiabank
Low
Report
AbbVie initiated with an Outperform at Scotiabank
11/12
04:17 pm
abbv
AbbVie initiated with an Outperform at Scotiabank
Low
Report
AbbVie initiated with an Outperform at Scotiabank
11/7
11:11 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
11/4
08:09 am
abbv
AbbVie (NYSE:ABBV) was downgraded by analysts at DZ Bank AG from a "buy" rating to a "hold" rating. They now have a $237.00 price target on the stock.
Low
Report
AbbVie (NYSE:ABBV) was downgraded by analysts at DZ Bank AG from a "buy" rating to a "hold" rating. They now have a $237.00 price target on the stock.
11/3
03:05 pm
abbv
Rating for ABBV
Low
Report
Rating for ABBV
11/3
03:05 pm
abbv
Rating for ABBV
Low
Report
Rating for ABBV
11/3
09:38 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
11/3
08:07 am
abbv
AbbVie (NYSE:ABBV) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
AbbVie (NYSE:ABBV) had its "neutral" rating reaffirmed by analysts at Citigroup Inc..
10/20
08:34 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
10/20
08:34 am
abbv
Rating for ABBV
Low
Report
Rating for ABBV
10/20
08:21 am
abbv
AbbVie (NYSE:ABBV) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
AbbVie (NYSE:ABBV) had its "buy" rating reaffirmed by analysts at Guggenheim.
10/20
08:21 am
abbv
AbbVie (NYSE:ABBV) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
AbbVie (NYSE:ABBV) had its "buy" rating reaffirmed by analysts at Guggenheim.